HIV Research in the Era of PrEP: The Implications of TDF/FTC for Biomedical Prevention Trials

The effectiveness and increasing availability of oral PrEP raises questions about how it should be incorporated into clinical trial designs for next-generation HIV prevention options. This paper explores ethics, the scientific literature to date, and advocates’ views on the issue.